Cycles of Aberrant Synaptic Sprouting and Neurodegeneration in Alzheimer's and Dementia with Lewy Bodies
The DOI matches its Crossref record; 151 of the 156 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are the most common neurodegenerative disorders affecting the elderly. The cognitive and motor deficits in these diseases are associated with the disruption of neuritic substructure, loss of synaptic contacts in selectively vulnerable circuitries, and aberrant sprouting. Where as in AD, accumulation of misfolded forms of Abeta triggers neurodegeneration, in DLB accumulation of alpha-synuclein might play a central role. The mechanisms by which oligomeric forms of these proteins might lead to cycles of synapse loss and aberrant sprouting are currently under investigation. Several possibilities are being considered, including mitochondrial damage, caspase activation, lysosomal leakage, fragmentation of the Golgi apparatus, interference with synaptic vesicle transport and function, and interference with gene transcription and signaling. Among them, recent lines of research support the possibility that alterations in signaling pathways such extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 relevant to synaptic plasticity and cell survival might play a pivotal role. A wide range of cellular functions are affected by the accumulation of misfolded Abeta and alpha-synuclein; thus it is possible that a more fundamental cellular alteration may underlie the mechanisms of synaptic pathology in these disorders. Among them, one possibility is that scaffold proteins, such as caveolin and JNK-interac…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“7), recent studies have shown that missense mutations (Ala53 to Thr, Ala30 to Pro) in -synuclein are associated with familial parkinsonism (125,126) and that mutant (mut) -synuclein is more prone to aggregate (127–129) and is the principal component of the LBs (120,122).”
BackgroundGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Self-citationMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Srimaroeng, C., Cecile, J. P., Walden, R., & Pritchard, J. B. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350077 · Cited by 2,989
Research works printed but not linked: 9
- Eccles, J. 1984. The cerebral neocortex: A theory of its operation. Pages 1-38, in Jones, E. and Peters, A. (eds.), Cerebral Cortex, Vol. 2, Functional Properties of Cortical Cells, New York, Plenum.
- Cotman, C. and Nadler, J. 1978. Reactive synaptogenesis in the hippocampus. Pages 227-271, in Cotman, C. (ed.), Neuronal Plasticity, New York, Raven.
- Cotman, C., Cummings, B., and Pike, C. 1993. Molecular cascades in adaptive versus pathological plasticity. Pages 217-240, in Gorio, A. (ed.), Neurodegeneration, New York, Raven.
- Terry, R., Hansen, L., and Masliah, E. 1994. Structural basis of the cognitive alterations in Alzheimer disease. Pages 179-196, in Terry, R. and Katzman, R. (eds.), Alzheimer Disease, New York, Raven.
- Masliah, E. and LiCastro, F. 2000. Neuronal and synaptic loss, reactive gliosis, microglial response, and induction of the complement cascade in Alzheimer's disease. Pages 131-146, in Clark, C. and Trojanowski, J. Neurodegenerative Dementias, New York, McGraw-Hill.
- Hof, P. and Morrison, J. 1994. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. Pages 197-230, in Terry, R., Katzman, R., and Bick, K. (eds.), Alzheimer Disease, New York, Raven.
- Anderson, B. 1995. Dendritic correlates of dementia severity in Alzheimer's disease. Med. Sci. Res. 23:597-599.
- Masliah, E. and Terry, R. 1994. The role of synaptic pathology in the mechanisms of dementia in Alzheimer's disease. Clin. Neurosci. 1:192-198.
- Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., and Mucke, L. 2001. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA 98:12245-12250. · DOI · Paper page
Cited by
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Garcia‐Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 661
Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595
“This model was selected because overexpression of -syn in these cells results in mitochondrial alterations, reduced cell viability, defective neurite outgrowth, and abnormal accumulation of oligomeric -syn (Takenouchi et al., 2001; Hashimoto and Masliah, 2003).”
BackgroundSelf-citationFunctional Alterations in Memory Networks in Early Alzheimer’s Disease
Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., Hedden, T., Becker, J. A., Rentz, D. M., Selkoe, D. J., et al. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8109-7 · Cited by 604
“Alternatively, increased regional brain activation may be a marker of the pathophysiologic process of AD itself, such as aberrant sprouting of cholinergic fibers (Hashimoto and Masliah 2003) or inefficiency in synaptic transmission (Stern et al. 2004).”
BackgroundMedial temporal lobe function and structure in mild cognitive impairment
Dickerson, B. C., Salat, D. H., Bates, J. F., Atiya, M., Killiany, R. J., Greve, D. N., Dale, A. M., Stern, C. E., Blacker, D., Albert, M. S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20163 · Cited by 566
Metadata
- Authors
- Hashimoto, M., & Masliah, E.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Masliah, Eliezer
- Venue
- Neurochemical Research
- Published
- 2003-11
- Volume
- 28
- Issue
- 11
- Pages
- 1743-1756
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W321625949
- Cited by
- 78
- References
- 156
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29ag010869-05)
- National Institute on Aging (P50AG005131, AG-5131, AG 18440, AG10869)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, dementia with Lewy bodies, synaptic loss, neurodegeneration, amyloid-beta, alpha-synuclein, protein oligomers, ERK signaling, JNK signaling, p38 MAPK, caveolin, synaptic plasticity, mitochondrial damage, Golgi fragmentation, synaptic vesicle transport, axonal plasticity
- MeSH terms
- Alzheimer Disease, Animals, Humans, Memory Disorders, Nerve Degeneration, Nerve Tissue Proteins, Neural Pathways, Synaptic Transmission, Neuronal Plasticity, Amyloid beta-Peptides, Neurites, Lewy Body Disease, Synucleins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.